Last Updated on: 3rd June 2021, 03:50 pm
Russia’s new vaccine against COVID-19, ‘CoviVac’, is found to be 80% more effective according to preliminary data, the Interfax news agency announced on Wednesday, citing the vaccine developer.
The Chumakov Center could produce six times more than the previously planned 10 million doses of the vaccine per year, added Interfax.
Also Read: Pakistan to approve 1m doses of Covid-19 vaccine from Pfizer
It should be noted that the Russian Sputnik-V vaccine was 91.6% effective in preventing the development of COVID-19, according to peer-reviewed results of its late-stage clinical trial published Tuesday in the International Medical The Lancet trade journal was published.
The scientists said the results of the Phase III study meant the world had another powerful weapon to fight the deadly pandemic and to some extent justified Moscow’s decision to launch the vaccine before the final data was released .
Also Read: Vietnam Found New UK-Indian Covid Variant That Spreads Quickly in Air
The results, compiled by the Gamaleya Institute in Moscow, which developed and tested the vaccine, were consistent with efficacy data reported in earlier phases of the study, which has been running in Moscow since September.
